Global Biomedical Refrigerators and Freezers Market Highlighting Regional Revenue Share Dominance During 2018 to 2025

Press Release

Hormonal Contraception is a type of pregnancy prevention technique acting on the endocrine system using various female hormones to prevent ovulation. Synthetic forms of hormones such as progestin and estrogen are used to prevent ovulation and avoid fertilization by altering the environment of the uterus. Hormonal contraceptives are available in various forms such as patches, injection, pills, Intrauterine Devices (IUD), etc.

Get More Information about:

Demand Scenario

The global hormonal contraceptive market was USD 18.28 billion in 2018 and is estimated to reach USD 23.83 billion by 2025 at a CAGR of 3.86% during the forecast period

Growth by Region

North America dominated the market owing to increasing awareness towards the benefits of using hormonal contraceptive, favourable regulatory scenario, higher awareness about sexual health and high prevalence of unwanted pregnancy. Asia-Pacific will witness the highest CAGR during the forecast period due to the presence of highly populated countries like India and China, where there is a greater need to control the growing population. Other factors which supplement the growth include introduction of new female contraception devices, rise in investment by market players, large fertile population and strong economic growth

 Request for Discount :

Drivers vs Constraints

The factors that drive the growth of the hormonal contraceptive market include increase in awareness about modern contraception methods, increasing significance of family planning, increasing investments by market players to develop innovative devices and supportive government regulations. Also, the implementation of temporary and low cost contraceptive practices instead of permanent contraception is the vital factor driving global market for hormonal contraception market. Some of the factors that hamper the growth of the market include health risks associated with the use of contraceptives, availability of alternate contraceptive methods, and the lack of social acceptance.

Industry Trends and Updates

In August 2018, Lupin launched Ethinyl Estradiol, Drospirenone, and Levomefolate Calcium tablets in the US market which are used to prevent pregnancy. In June 2018, Glenmark Pharmaceuticals received the final approval from the US health regulator for generic versions of Loestrin tablets which are used to prevent pregnancy. In March 2017, TEVA launched the generic version of Minastrin 24 Fe-ethinyl estradiol & norethindrone acetate tablets and ferrous fumarate tablets. In February 2017, Medicines 360 and Allergan announced partnership with health centers to help address unintended pregnancies in areas such as Puerto Rico and Florida. The partnership has helped in increasing access to a hormonal contraceptive of the company in the region

Report Description:


About Us:

Trends Market Research is one of the leading digital services provider and a result-oriented company based in U.K… We are a team of enthusiastic-driven individuals with top notch skills in SEO, Market research. Trends Market Research is a one stop shop to all your business needs. We help you thrive and succeed. We provide research solution.

Our digital and enterprise research assurance solutions are ideal for Automotive & Transportation, Electronics & Semiconductor, Chemicals & Materials, Healthcare, Pharmaceuticals & Medical Devices, Food & Beverage and Industrial Automation as well as all type of other leading industries verticals. We offer a vast line of in-depth study of industry trends including customized & client oriented specific requirement.

Contact Us:

One Vincent Square
Westminster, London SW1P 2PN
United Kingdom
Email: [email protected] 
Follow me on :

This post was originally published on Market Reports